Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:1357-1358 (13 December), doi:10.1136/bmj.327.7428.1357
The lessons are general (and for many patients) rather than specific to that war
| The first 150 words of the full text of this article appear below. |
Two papers in this issue of the BMJ describe the long term health of British veterans of the 1990-1 Gulf war. In the article by Hotopf et al the King's Gulf war illnesses research group present another excellent study, this one indicating that 11 years after the conflict the Gulf veterans continue to experience considerably poorer health than control groups (p 1370).1 The article by Macfarlane et al examines the rate of malignancy in Gulf war veterans and shows that their overall rate of cancer is almost identical to those not deployed, even among those reporting exposure to potentially carcinogenic factors such as depleted uranium or pesticides (p 1373).2 These results are congruent with other data collected in both UK and US Gulf war veterans. Twelve years after the war, and after roughly $300m (£174m;
250m) has been spent on research, what do we know about
Daniel Clauw, professor of rheumatology
(dclauw@umich.edu) University of Michigan, PO Box 385, Ann Arbor, MI 48106, USA
Read all Rapid Responses